Inflammation and neurodegeneration: The story 'retolled'

Trends in Pharmacological Sciences

Volumn 33, Issue 10, 2012, Pages 542-551

  Drouin Ouellet, Janelle ^a   Cicchetti, Francesca ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

synucleinopathy; amyloid plaques; Alzheimer's disease; dopaminergic degeneration; Parkinson's disease; Toll like receptors

Indexed keywords

ALPHA SYNUCLEIN; ANTIINFLAMMATORY AGENT; ERITORAN; IBUDILAST; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ALZHEIMER DISEASE; CLINICAL EFFECTIVENESS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; IMMUNOGENETICS; IMMUNOREACTIVITY; INFLAMMATION; INNATE IMMUNITY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NEUROPATHIC PAIN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TREATMENT DURATION; WITHDRAWAL SYNDROME;

ALZHEIMER DISEASE; ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; PARKINSON DISEASE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84866734401     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.07.002     Document Type: Review

References (113)

1. P.L. McGeer, and E.G. McGeer History of innate immunity in neurodegenerative disorders Front. Pharmacol. 2 2011 77
2. S. Amor Inflammation in neurodegenerative diseases Immunology 129 2010 154 169
3. C.K. Glass Mechanisms underlying inflammation in neurodegeneration Cell 140 2010 918 934
4. E.C. Hirsch, and S. Hunot Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 8 2009 382 397
5. S. Mandrekar-Colucci, and G.E. Landreth Microglia and inflammation in Alzheimer's disease CNS Neurol. Disord. Drug Targets 9 2010 156 167
6. C.A. Colton, and D.M. Wilcock Assessing activation states in microglia CNS Neurol. Disord. Drug Targets 9 2010 174 191
7. A. Michelucci Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-β J. Neuroimmunol. 210 2009 3 12
8. T. Town The microglial 'activation' continuum: from innate to adaptive responses J. Neuroinflamm. 2 2005 24
9. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat. Rev. Immunol. 5 2005 953 964 (Pubitemid 41746764)
10. F.O. Martinez Macrophage activation and polarization Front. Biosci. 13 2008 453 461 (Pubitemid 351599757)
11. E. Okun Toll-like receptors in neurodegeneration Brain Res. Rev. 59 2009 278 292
12. T. Kawai, and S. Akira The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors Nat. Immunol. 11 2010 373 384
13. S. Akira Pathogen recognition and innate immunity Cell 124 2006 783 801 (Pubitemid 43261452)
14. L. Apetoh Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nat. Med. 13 2007 1050 1059 (Pubitemid 47517504)
15. A. Asea Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4 J. Biol. Chem. 277 2002 15028 15034 (Pubitemid 34952579)
16. Q.Q. Huang Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling J. Immunol. 182 2009 4965 4973
17. A.B. Prakken T-cell reactivity to human HSP60 in oligo-articular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint Immunol. Lett. 57 1997 139 142 (Pubitemid 27319327)
18. C.S. Jack TLR signaling tailors innate immune responses in human microglia and astrocytes J. Immunol. 175 2005 4320 4330 (Pubitemid 41361966)
19. M. Bsibsi Broad expression of Toll-like receptors in the human central nervous system J. Neuropathol. Exp. Neurol. 61 2002 1013 1021 (Pubitemid 35278723)
20. S. Lehnardt A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia J. Immunol. 177 2006 583 592 (Pubitemid 43939172)
21. A. Setzu Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells Glia 54 2006 297 303 (Pubitemid 44316234)
22. B.B. Mishra Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis J. Neuroimmunol. 181 2006 46 56 (Pubitemid 44827289)
23. S.C. Tang Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits Proc. Natl. Acad. Sci. U.S.A. 104 2007 13798 13803
24. Y. Ma Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis J. Cell Biol. 175 2006 209 215 (Pubitemid 44631415)
25. A. Rolls Toll-like receptors modulate adult hippocampal neurogenesis Nat. Cell Biol. 9 2007 1081 1088 (Pubitemid 47338146)
26. P. Nagyoszi Expression and regulation of Toll-like receptors in cerebral endothelial cells Neurochem. Int. 57 2010 556 564
27. M. Marta Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis Eur. J. Immunol. 38 2008 565 575
28. J. Drouin-Ouellet The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration J. Neuroinflamm. 8 2011 137
29. M.A. Panaro Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson's-like disease Immunopharmacol. Immunotoxicol. 30 2008 729 740
30. F. Ros-Bernal Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism Proc. Natl. Acad. Sci. U.S.A. 108 2011 6632 6637
31. N. Stefanova Microglial activation mediates neurodegeneration related to oligodendroglial α-synucleinopathy: implications for multiple system atrophy Mov. Disord. 22 2007 2196 2203
32. H. Jang Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration Proc. Natl. Acad. Sci. U.S.A. 106 2009 14063 14068
33. M.P. Mattson Infectious agents and age-related neurodegenerative disorders Ageing Res. Rev. 3 2004 105 120 (Pubitemid 38177441)
34. C.A. Ross, and M.A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 10 Suppl. 2004 S10 S17
35. H. Braak, and E. Braak Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex J. Neural Transm. Park. Dis. Dement. Sect. 2 1990 45 57 (Pubitemid 20215381)
36. D. Galasko Clinical-neuropathological correlations in Alzheimer's disease and related dementias Arch. Neurol. 51 1994 888 895 (Pubitemid 24286043)
37. K.M. Lucin, and T. Wyss-Coray Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64 2009 110 122
38. K. Fassbender The LPS receptor (CD14) links innate immunity with Alzheimer's disease FASEB J. 18 2004 203 205
39. M. Letiembre Screening of innate immune receptors in neurodegenerative diseases: a similar pattern Neurobiol. Aging 30 2009 759 768
40. Y. Liu LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide Brain 128 2005 1778 1789 (Pubitemid 41373649)
41. E.G. Reed-Geaghan CD14 and Toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation J. Neurosci. 29 2009 11982 11992
42. K.L. Richard Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease J. Neurosci. 28 2008 5784 5793
43. S. Walter Role of the Toll-like receptor 4 in neuroinflammation in Alzheimer's disease Cell. Physiol. Biochem. 20 2007 947 956 (Pubitemid 350059737)
44. W. Hao Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology Brain 134 2011 278 292
45. J.P. Michaud MyD88-adaptor protein acts as a preventive mechanism for memory deficits in a mouse model of Alzheimer's disease Mol. Neurodegener. 6 2011 5
46. J.P. Michaud Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's Disease Stem Cell Rev. 2012 10.1007/s12015-012-9356-9
47. G. DiCarlo Intraahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice Neurobiol. Aging 22 2001 1007 1012
48. D.L. Herber Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice Exp. Neurol. 190 2004 245 253 (Pubitemid 39335723)
49. T.M. Malm Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice Neurobiol. Dis. 18 2005 134 142 (Pubitemid 40092904)
50. J. Quinn Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease J. Neuroimmunol. 137 2003 32 41 (Pubitemid 36351563)
51. J.G. Sheng Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice Neurobiol. Dis. 14 2003 133 145 (Pubitemid 37103187)
52. D.C. Lee LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice J. Neuroinflamm. 7 2010 56
53. M. Kitazawa Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J. Neurosci. 25 2005 8843 8853 (Pubitemid 41384452)
54. H. Braak Stages in the development of Parkinson's disease-related pathology Cell Tissue Res. 318 2004 121 134 (Pubitemid 39362633)
55. D.R. Brown Oligomeric α-synuclein and its role in neuronal death IUBMB Life 62 2010 334 339
56. D.P. Karpinar Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models EMBO J. 28 2009 3256 3268
57. J.A. Wright Unique copper-induced oligomers mediate α-synuclein toxicity FASEB J. 23 2009 2384 2393
58. D. Beraud α-Synuclein alters Toll-like receptor expression Front. Neurosci. 5 2011 80
59. W. Zhang Aggregated α-synuclein activates microglia: a process leading to disease progression in Parkinson's disease FASEB J. 19 2005 533 542 (Pubitemid 40471244)
60. E.J. Lee α-Synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1 J. Immunol. 185 2010 615 623
61. X. Su Synuclein activates microglia in a model of Parkinson's disease Neurobiol. Aging 29 2008 1690 1701
62. S. Theodore Targeted overexpression of human α-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease J. Neuropathol. Exp. Neurol. 67 2008 1149 1158
63. H.M. Gao Neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration J. Neurosci. 28 2008 7687 7698
64. M.G. Spillantini, and M. Goedert The α-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy Ann. N. Y. Acad. Sci. 920 2000 16 27 (Pubitemid 32056547)
65. N. Stefanova Toll-Like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons Am. J. Pathol. 179 2011 954 963
66. K. Chen Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide J. Biol. Chem. 281 2006 3651 3659 (Pubitemid 43845983)
67. S. Lehnardt Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proc. Natl. Acad. Sci. U.S.A. 100 2003 8514 8519 (Pubitemid 36842576)
68. O. Adachi Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function Immunity 9 1998 143 150 (Pubitemid 28361303)
69. T. Kawai Unresponsiveness of MyD88-deficient mice to endotoxin Immunity 11 1999 115 122 (Pubitemid 29359962)
70. J. Drouin-Ouellet Myd88 deficiency results in both cognitive and motor impairments in mice Brain Behav. Immun. 26 2012 880 885
71. M. Cote The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity Brain Behav. Immun. 25 2011 1143 1152
72. V. Brochard Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease J. Clin. Invest. 119 2009 182 192
73. E. Kokovay, and L.A. Cunningham Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease Neurobiol. Dis. 19 2005 471 478 (Pubitemid 40968060)
74. I. Kurkowska-Jastrzebska The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse Exp. Neurol. 156 1999 50 61 (Pubitemid 29152982)
75. M. Rodriguez Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease Neurobiol. Dis. 28 2007 316 325 (Pubitemid 350116601)
76. M. Lalancette-Hebert Live imaging of Toll-like receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation Brain 132 2009 940 954
77. J.K. Olson, and S.D. Miller Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs J. Immunol. 173 2004 3916 3924 (Pubitemid 39280755)
78. G. Trinchieri, and A. Sher Cooperation of Toll-like receptor signals in innate immune defence Nat. Rev. Immunol. 7 2007 179 190
79. M. Deleidi The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration J. Neurosci. 30 2010 16091 16101
80. J. Waak Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1 FASEB J. 23 2009 2478 2489
81. I. Martin Recent advances in the genetics of Parkinson's disease Annu. Rev. Genomics Hum. Genet. 12 2011 301 325
82. Kalinderi, K. et al. (2012) TLR9-1237 T/C and TLR2-194 to -174 del polymorphisms and the risk of Parkinson's disease in the Greek population: a pilot study. Neurol. Sci. http://dx.doi.org/10.1007/s10072-012-1106-x
83. J.J. Lin A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females Parkinsonism Relat. Disord. 12 2006 9 13 (Pubitemid 43037147)
84. C. Klein Deciphering the role of heterozygous mutations in genes associated with parkinsonism Lancet Neurol. 6 2007 652 662 (Pubitemid 46921058)
85. J. Thevenet Regulation of LRRK2 expression points to a functional role in human monocyte maturation PLoS ONE 6 2011 e21519
86. F. Gillardon Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity Neuroscience 208 2012 41 48
87. M.S. Moehle LRRK2 inhibition attenuates microglial inflammatory responses J. Neurosci. 32 2012 1602 1611
88. M. Hakimi Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures J. Neural. Transm. 118 2011 795 808
89. T.A. Tran Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-κB PLoS ONE 6 2011 e23660
90. F.J. Barrat, and R. L Coffman Development of TLR inhibitors for the treatment of autoimmune diseases Immunol. Rev. 223 2008 271 283 (Pubitemid 351986175)
91. E. Lin Innate immunity and Toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases Cardiovasc. Ther. 27 2009 117 123
92. E.Y. So, and T. Ouchi The application of Toll like receptors for cancer therapy Int. J. Biol. Sci. 6 2010 675 681
93. J.G. Vallejo Role of Toll-like receptors in cardiovascular diseases Clin. Sci. (Lond.) 121 2011 1 10
94. T. Ha Toll-like receptors: new players in myocardial ischemia/reperfusion injury Antioxid. Redox Signal. 15 2011 1875 1893
95. A. Ledeboer Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes Expert Opin. Investig. Drugs 16 2007 935 950 (Pubitemid 47078775)
96. A. Ledeboer The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain Neuron Glia Biol. 2 2006 279 291 (Pubitemid 47074741)
97. F. Barkhof Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant? Neurology 74 2010 1033 1040
98. F. Arslan Treatment with OPN-305, a humanized anti-Toll-like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs Circ. Cardiovasc. Interv. 5 2012 279 287
99. F. Pan-Montojo Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice PLoS ONE 5 2010 e8762
100. A. Ulusoy Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease Prog. Brain Res. 184 2010 89 111
101. P. Iribarren CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2 FASEB J. 19 2005 2032 2034 (Pubitemid 41759755)
102. P. Minoretti Effect of the functional Toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease Neurosci. Lett. 391 2006 147 149 (Pubitemid 41736189)
103. K. Tahara Role of Toll-like receptor signalling in Aβ uptake and clearance Brain 129 2006 3006 3019 (Pubitemid 44684521)
104. S.C. Tang Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal Exp. Neurol. 213 2008 114 121
105. Y. Doi Microglia activated with the Toll-like receptor 9 ligand CpG attenuate oligomeric amyloid β neurotoxicity in in vitro and in vivo models of Alzheimer's disease Am. J. Pathol. 175 2009 2121 2132
106. H. Scholtzova Induction of Toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology J. Neurosci. 29 2009 1846 1854
107. J. Kang, and S. Rivest MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis J. Cell Biol. 179 2007 1219 1230 (Pubitemid 350277740)
108. W. Zhao Extracellular mutant SOD1 induces microglial-mediated motoneuron injury Glia 58 2010 231 243
109. D.S. Spinner Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice J. Virol. 82 2008 10701 10708 (Pubitemid 352691158)
110. V. Beringue Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis J. Pathol. 190 2000 495 502 (Pubitemid 30163592)
111. S. Sethi Postexposure prophylaxis against prion disease with a stimulator of innate immunity Lancet 360 2002 229 230 (Pubitemid 34804655)
112. M.D. Nguyen Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis J. Neurosci. 24 2004 1340 1349 (Pubitemid 38222984)
113. M. Prinz Prion pathogenesis in the absence of Toll-like receptor signalling EMBO Rep. 4 2003 195 199 (Pubitemid 36322162)